Freespira’s digital therapeutic for panic disorder and PTSD chosen as top pioneering solution to improve health outcomes and increase affordability…
New executive brings commercialization expertise to ground-breaking digital therapeutics company KIRKLAND, Wash., June 7, 2022 /PRNewswire/ — Freespira, Inc., maker of the first…
Wisconsin health plan makes Freespira treatment available to commercially insured and Medicaid members KIRKLAND, Wash., July 13, 2022 /PRNewswire/ — Freespira, Inc., maker of…
Startups have raised billions of dollars in venture capital to develop software-based digital therapeutics for a range of diseases. Now,…
In April 2020, as the horrors of the pandemic were beginning to unspool, the Food and Drug Administration announced an…
Recognition represents key milestone in fast-growing company’s journey towards continuous quality and accessibility for third-party payments KIRKLAND, Wash., April 19, 2022…
They are rapidly becoming an important part of health care. Though chronic-care apps are likely to become the blockbuster category…
The Children’s Community Health Plan is using a digital therapeutic to improve patient engagement and give members dealing with panic…
Robert Cuyler, PhD is the Chief Clinical Officer of Freespira. Dr. Cuyler is a nationally recognized expert on telemedicine and…
